TM
TMO
Quarter ended Jun 29, 2024 · FY2024 Q2

Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Jun 29, 2024

Reported revenue increased from the prior quarter. However, it declined compared to the same quarter one year earlier.

Key takeaway

Quarter ended Jun 29, 2024 · FY2024 Q2

Reported revenue increased from the prior quarter. However, it declined compared to the same quarter one year earlier.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$10.5B

Revenue reported for this quarter.

Quarter-over-quarter

+1.9%

Change from the immediately preceding quarter.

Year-over-year

-1.4%

Change from the comparable year-ago quarter.

Trailing four quarters

$42.3B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Sep 30, 2023$10.6B-1.0%
Dec 31, 2023$10.9B-4.9%
Mar 30, 2024$10.3B-3.4%
Jun 29, 2024$10.5B-1.4%

Revenue performance

The quarter-over-quarter improvement shows a rebound from the previous period. The year-over-year decline indicates continued pressure relative to the prior year.

Quarterly comparison

Compared to the immediately preceding quarter, revenue rose, reversing the prior sequential decline. Compared to the same quarter one year ago, revenue was lower, extending the year-over-year downward trend.

What to watch

Monitor whether the quarter-over-quarter rebound continues or if the year-over-year contraction persists.